1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 20 OCTOBER 2014

Cancer Drug News 20 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Fully Personalised Cancer Vaccines On The Rise
Industry Trend Analysis - Pfizer's Palbociclib On Route For 2015 Launch
Industry Brief - Galena Receives Japanese Patent Allowance Covering NeuVax
Industry Brief - Pharmacyclics/Roche Enter Deal To Evaluate Imbruvica/Gazyva In Lymphoma And Leukaemia
Industry Trend Analysis - Imbruvica Has A Fighting Chance In CLL Market
Industry Trend Analysis - J&J Bolsters Immunotherapy Pipeline With Second Aduro Collaboration
Industry Trend Analysis - Nanobiotix' NBTXR3 To Make The Unresectable Resectable
Industry Brief - Eisai's Lenvatinib Gains FDA Priority Review Designation For RAI-Refractory DTC
Industry Brief - Nanobiotix Earns Second Milestone Payment From Bpifrance For NBTXR3 Development
Industry Brief - Immutep Receives Australian NoA For Patent Covering IMP321
Industry Brief - Heidelberg/Roche Extend Collaboration To Develop ATACs
Industry Brief - COT Adds Canadian Patent To COTI-2 Intellectual Property Portfolio
Industry Trend Analysis - Roche Bets On NewLink With USD1bn Deal
Industry Brief - OctreoPharm's OPS202 Gains FDA ODD For NETs
Industry Brief - Rigontec Raises Funds To Advance RNA-Based Immunotherapeutics For Cancer/Viral Diseases
Industry Brief - DNAtrix Raises Funds To Advance DNX-2401 In Glioblastoma
Industry Brief - Daiichi Sankyo Submits Tender Offer For Shares In Ambit Biosciences
Industry Brief - Bicycle Raises Funds For Development Of BDCs In Oncology
Industry Trend Analysis - Roche's Oncology Portfolio Reinforcement Securing Growth

Table Of Contents

Cancer Drug News 20 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 10 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6 650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.